ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 303 filers reported holding ALKERMES PLC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $267,552 | -5.7% | 9,552 | +5.4% | 0.01% | 0.0% |
| Q2 2023 | $283,578 | +14.2% | 9,060 | +2.8% | 0.01% | +7.7% |
| Q1 2023 | $248,354 | -7.6% | 8,810 | -14.3% | 0.01% | +8.3% |
| Q4 2022 | $268,643 | -8.2% | 10,281 | +4.6% | 0.01% | -7.7% |
| Q2 2022 | $292,776 | +13.2% | 9,828 | 0.0% | 0.01% | +44.4% |
| Q1 2022 | $258,575 | -73.6% | 9,828 | -76.7% | 0.01% | -30.8% |
| Q4 2021 | $980,107 | -24.6% | 42,137 | 0.0% | 0.01% | -31.6% |
| Q3 2021 | $1,299,505 | +20.4% | 42,137 | -4.2% | 0.02% | +26.7% |
| Q2 2021 | $1,078,880 | +1707.1% | 44,000 | +1276.7% | 0.02% | +1400.0% |
| Q1 2021 | $59,701 | -2.6% | 3,196 | +4.0% | 0.00% | 0.0% |
| Q4 2020 | $61,286 | -1.7% | 3,072 | -4.4% | 0.00% | 0.0% |
| Q2 2020 | $62,348 | -15.2% | 3,213 | -14.7% | 0.00% | 0.0% |
| Q3 2019 | $73,514 | -71.2% | 3,768 | -66.8% | 0.00% | -75.0% |
| Q2 2019 | $255,536 | -39.6% | 11,337 | -2.3% | 0.00% | -50.0% |
| Q1 2019 | $423,248 | +21.1% | 11,599 | -2.0% | 0.01% | +14.3% |
| Q4 2018 | $349,428 | -99.9% | 11,841 | -2.3% | 0.01% | -12.5% |
| Q2 2018 | $498,695,000 | -24.4% | 12,116 | +6.4% | 0.01% | -11.1% |
| Q1 2018 | $659,701,000 | +105791.0% | 11,382 | +0.0% | 0.01% | +12.5% |
| Q4 2017 | $623,000 | +6.7% | 11,379 | -0.9% | 0.01% | +100.0% |
| Q3 2017 | $584,000 | -7.6% | 11,486 | +5.4% | 0.00% | 0.0% |
| Q2 2017 | $632,000 | +4.6% | 10,900 | +5.5% | 0.00% | 0.0% |
| Q1 2017 | $604,000 | +5.2% | 10,329 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $574,000 | +13.0% | 10,329 | -4.3% | 0.00% | 0.0% |
| Q3 2016 | $508,000 | +3.9% | 10,794 | -4.6% | 0.00% | 0.0% |
| Q2 2016 | $489,000 | +4.7% | 11,312 | +23.4% | 0.00% | +33.3% |
| Q2 2014 | $467,000 | +3.1% | 9,164 | -1.6% | 0.00% | 0.0% |
| Q1 2014 | $453,000 | +28.0% | 9,310 | +7.1% | 0.00% | +50.0% |
| Q4 2013 | $354,000 | +21.2% | 8,696 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $292,000 | +15.4% | 8,696 | -1.3% | 0.00% | 0.0% |
| Q2 2013 | $253,000 | – | 8,812 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |